Search - tctmd.com

Displaying 541 - 560 of 1054

Sort: Relevancy | Date

News Industry News

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

June 23, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

L.A. McKeown

June 17, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Daily News

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Daily News

El Flujo VI Post-TAVR Predice la Mortalidad Tardía

June 11, 2015

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Transfemoral Vascular Complications

Presenter: Augusto D. Pichard

June 05, 2015

Presentation TVT 2015

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

Presenter: Nicolo Piazza

June 04, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Presenter: David A. Wood

June 04, 2015

Presentation TVT 2015

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Presenter: Raj Makkar, Mathew Williams, Thomas G. Gleason

June 04, 2015

Presentation TVT 2015

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Presenter: Raj Makkar, Mathew Williams, Vasilis Babaliaros

June 04, 2015

Presentation TVT 2015

Transcaval TAVR: Technique, Rationale, and Complications

Presenter: Raj Makkar, Mathew Williams, Adam B. Greenbaum

June 04, 2015

Presentation TVT 2015

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, A. Pieter Kappetein

June 04, 2015

Presentation TVT 2015

Direct Aortic TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Michael J. Reardon

June 04, 2015

Presentation TVT 2015

Transapical TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Thomas Walther

June 04, 2015

Presentation TVT 2015

Be Prepared! Management of Major Vascular Complications

Presenter: Raj Makkar, Mathew Williams

June 04, 2015

Advertisement

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

LV Flow After TAVR Predicts Late Mortality

El Flujo VI Post-TAVR Predice la Mortalidad Tardía

New Transfemoral Access Closure Devices

Avoiding and Managing Transfemoral Vascular Complications

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

The North American 3M TAVR Study: Evaluating the Efficacy, Feasibility, and Safety of Next-Day Discharge Home in Patients Undergoing Elective Transfemoral TAVR

Direct Aortic vs Subclavian-Axillary TAVR: Lessons From the CoreValve Pivotal Trial

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Transcaval TAVR: Technique, Rationale, and Complications

Subclavian-Axillary TAVR: Optimal Technique and Complication Management

Direct Aortic TAVR: Optimal Technique and Complication Management

Transapical TAVR: Optimal Technique and Complication Management

Be Prepared! Management of Major Vascular Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content